Description
Worldwide expenditure on R&D by the pharmaceutical industry is continually increasing. Most of the financial investment in the production of a new drug is allocated to clinical trials.
Given the financial risk involved, it is crucially important that clinical trials be designed and set up efficiently to obtain adequate and accurate data in compliance with regulatory requirements.
This module aims to provide information on the statistical elements of clinical trials. This session covers the role of statistics in clinical trial design and analysis, as acknowledged in the International Council for Harmonization (ICH) guideline for Good Clinical Practice (GCP).
